L.P. ACORN BIOVENTURES - 23 Jan 2026 SCHEDULE 13G/A Report for Jasper Therapeutics, Inc. Common Stock, $0.001 Par Value (JSPR)

Filing Manager
L.P. ACORN BIOVENTURES
Reporting Manager
Anders Hove
Security
Jasper Therapeutics, Inc. Common Stock, $0.001 Par Value
Symbol
JSPR
Shares outstanding
28,047,019 shares
Disclosed Ownership
1,486,492 shares
Ownership
5.3%
Form type
SCHEDULE 13G/A
Filing time
26 Jan 2026, 15:29:02 UTC
Date of event
23 Jan 2026
Previous filing
02 Dec 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ACORN BIOVENTURES, L.P. 2.2% 624,326 0 624,326 Anders Hove Manager of General Partner
ACORN CAPITAL ADVISORS GP, LLC 2.2% 624,326 0 624,326 Anders Hove Manager
ACORN BIOVENTURES 2, L.P. 3.1% 862,166 0 862,166 Anders Hove Manager of General Partner
Acorn Capital Advisors GP 2, LLC 3.1% 862,166 0 862,166 Anders Hove Manager
Anders Hove 5.3% 1,486,492 0 1,486,492 Anders Hove Individually